Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

PLRZ Polyrizon Ltd

1,6283

0,1683 (11,53%)

18 Jan 2025 - Geschlossen

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Polyrizon (NASDAQ:PLRZ)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Polyrizon Charts.

Polyrizon (NASDAQ:PLRZ)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Polyrizon Charts.

News Polyrizon Ltd

Form EFFECT - Notice of Effectiveness
Donnerstag 16 Januar 2025 (4 Tage vor) • Edgar (US Regulatory)

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
Freitag 10 Januar 2025 (1 Woche vor) • Edgar (US Regulatory)

Form F-1 - Registration statement for certain foreign private issuers
Montag 30 Dezember 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Montag 30 Dezember 2024 (3 Wochen vor) • Edgar (US Regulatory)

Polyrizon Announces Publication of U.S. National Patent Application for Its Innovative Hydrogel Nasal Technologies
Montag 30 Dezember 2024 (3 Wochen vor) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Donnerstag 19 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Polyrizon Appoints Dr. Michal Meir as Senior Director of Regulatory and Clinical Affairs
Donnerstag 19 Dezember 2024 (1 Monat vor) • GlobeNewswire Inc.

Polyrizon's Moving Forward with Expected 2025 Clinical Trial - Entered Manufacturing Agreement for its PL-14 Allergy Blocker
Mittwoch 18 Dezember 2024 (1 Monat vor) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Freitag 13 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Polyrizon Announces Appointment of VP of Regulatory Affairs and Quality Assurance
Freitag 13 Dezember 2024 (1 Monat vor) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Montag 2 Dezember 2024 (2 Monate vor) • Edgar (US Regulatory)

Polyrizon Enters into GMP Manufacturing Agreement for CTM Supply of its PL-14 Allergy Blocker in Preparation for Planned 2025 Clinical Trial
Montag 2 Dezember 2024 (2 Monate vor) • GlobeNewswire Inc.

Weitere Polyrizon Ltd News-Artikel

Deutsche Telekom

Gold vs US Dollar

Euro vs US Dollar

Invesco QQQ Trust Series 1

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen